Condition
Newly Diagnosed Breast Cancer
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Terminated2
Not Yet Recruiting1
Completed1
Unknown1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07434817Not ApplicableNot Yet Recruiting
Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment
NCT01722851Completed
Circulating miRNAs.
NCT03510988Not ApplicableTerminatedPrimary
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
NCT01176838TerminatedPrimary
A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
NCT01064427UnknownPrimary
Factors Correlated With Fatigue in Breast Cancer
Showing all 5 trials